Thank you for sharing!

Your article was successfully shared with the contacts you provided.
Gavel with drugs If pharmaceutical companies aren’t forthright about their role in increasing list prices, senators on both sides of the aisle will become more combative. (Photo: Shutterstock)

Pharmaceutical executives looking to blame drug-plan middlemen for rising prescription costs at a Senate committee hearing this week will be greeted skeptically by lawmakers, said people familiar with the panel’s preparations.


Join BenefitsPRO

Don’t miss crucial news and insights you need to navigate the shifting employee benefits industry. Join BenefitsPRO.com now!

  • Unlimited access to BenefitsPRO.com - your roadmap to thriving in a disrupted environment
  • Access to other award-winning ALM websites including ThinkAdvisor.com and Law.com
  • Exclusive discounts on BenefitsPRO.com and ALM events.

Already have an account? Sign In Now
Join BenefitsPRO

Copyright © 2019 ALM Media Properties, LLC. All Rights Reserved.